Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.3173 +0.0127 (+4.17%)
Streaming Delayed Price Updated: 2:29 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 Next >
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces CFO Transition
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity 
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Third Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
New products complement an already extensive range of products enabling fundamental advancements in neuroscience research 
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development 
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Second Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces First Quarter 2024 Financial Results
Strong gross margin performance and focus on efficiency to support ongoing investments in growth 
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics 
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Third Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
Innovative solutions for academic, CRO, pharma and biotech customers 
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
From Harvard Bioscience, Inc.; Etisense
Via GlobeNewswire
Harvard Bioscience Announces Second Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.